We observed that the hepatic expression levels of both Wee1-AS and its downstream Wee1 were elevated under the pathological conditions of MASLD, which may indicate the presence of a compensatory mechanism in the regulation of these genes under disease conditions. Here, WEE1 is linked to metabolic dysfunction-associated steatotic liver disease.